Demo Sign up Log In

Mesabi Trust Common Stock (MSB)

Operating Expenses

$0.00

Quarterly · Period ending: Jul 31, 2026 · USD

MSB Operating Expenses

Latest reported$0.00period endingJul 31, 2026

Latest reported$0.00period endingJul 31, 2026

MSB Quarterly Operating Expenses ($2.50M → $0.00)

Quarterly operating expenses

High-resolution chart · PNG

MSB operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Mesabi Trust Common Stock Operating Expenses — Quarterly (USD)
Period ending	Operating Expenses (USD)
Jul 31, 2001	60,982
Apr 30, 2001	422,557
Jan 31, 2001	145,846
Oct 31, 2000	80,683
Jul 31, 2000	89,358
Apr 30, 2000	352,210
Jan 31, 2000	689,465
Oct 31, 1999	-100,000
Jul 31, 1999	-100,000
Apr 30, 1999	-100,000
Jan 31, 1999	553,386
Oct 31, 1998	-100,000
Jul 31, 1998	-100,000
Apr 30, 1998	-100,000
Jan 31, 1998	562,373
Oct 31, 1997	-100,000
Jul 31, 1997	-100,000
Apr 30, 1997	-100,000
Jan 31, 1997	581,534
Oct 31, 1996	-100,000
Jul 31, 1996	-100,000
Apr 30, 1996	-100,000
Jan 31, 1996	687,180
Oct 31, 1995	1,400,000
Jul 31, 1995	-100,000
Apr 30, 1995	-100,000
Jan 31, 1995	1,000,000
Oct 31, 1994	-100,000
Jul 31, 1994	-100,000
Apr 30, 1994	200,000
Jan 31, 1994	1,000,000
Oct 31, 1993	-100,000
Jul 31, 1993	-100,000
Apr 30, 1993	-100,000
Jan 31, 1993	-100,000
Oct 31, 1992	-100,000
Jul 31, 1992	-100,000
Apr 30, 1992	-100,000
Jan 31, 1992	300,000
Oct 31, 1991	800,000
Jul 31, 1991	0
Apr 30, 1991	200,000
Jan 31, 1991	600,000
Oct 31, 1990	700,000
Jul 31, 1990	700,000
Apr 30, 1990	200,000
Jan 31, 1990	200,000
Oct 31, 1989	300,000
Jul 31, 1989	100,000
Apr 30, 1989	100,000
Jan 31, 1989	400,000
Oct 31, 1988	100,000
Jul 31, 1988	100,000
Apr 30, 1988	0
Jan 31, 1988	400,000
Oct 31, 1987	0
Jul 31, 1987	0
Apr 30, 1987	100,000
Jan 31, 1987	700,000
Oct 31, 1986	100,000
Jul 31, 1986	100,000
Apr 30, 1986	1,300,000
Jan 31, 1986	500,000
Oct 31, 1985	2,500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.